Home > Healthcare & Medical Devices > Bioactive Coating Devices Market
Bioactive Coating Devices Market size will go through significant expansion over 2023-2032. The growing prevalence of joint problems and heart diseases leading to an upsurge in the number of cardiovascular & orthopedic surgeries will foster the demand for these devices.
A continuous surge in the use of blood-contacting implantable devices like heart valves, stents, extracorporeal support systems, vascular grafts, ventricular assist devices will propel the industry outlook over the foreseeable future. Thin bioactive films on implantable devices prevent clotting or inflammation and enhance local tissue repair and device integration. The application of these devices has significantly reduced the replacement and corrective surgical procedures.
The rise in number of hip and knee implant surgeries among the obese and aging population is likely to bolster the bioactive coating devices market outlook.
There was increased R&D investment observed among by eminent market players to introduce new and improved technologically advanced products and inflating government expenditure to improve healthcare infrastructure is likely to elevate industry share through 2032.
Based on the product, the market share from antimicrobial coatings segment may see substantial gains over the analysis timeframe. Antimicrobial coatings consist of chemicals that hinder the growth of disease-causing microbes on a surface and increase its corrosion resistance, durability, and appearance. These coatings are gaining traction due to their several benefits like lasting protection against pathogens, longer lifespan, cost-effectiveness, improved health and cleanliness, and additional infrastructure value.
With respect to the applications, bioactive coating devices market share from stents will register significant revenue trends, driven by the prevalence of cardiovascular diseases among the aging population. According to the World Health Organization, cardiovascular disorders account for 17.9 million NCD (noncommunicable diseases) deaths per year. The bioactive coating on stents prevents them from contamination and improves their reliability, functionality, and life span, significantly reducing the risk of corrective surgical procedures.
Diagnostic centers may emerge as major end-uses over the forecast timeframe due to the availability of advanced equipment and skilled and certified medical staff. Furthermore, the increasing requirement for better supervision and treatment along with the healthcare infrastructure improvements will support the segment expansion from 2023 to 2032.
North America bioactive coating devices market is likely to expand considerably in the forthcoming years, owing to the availability of advanced healthcare facilities and favorable reimbursement policies in the region. A rapid upsurge in the geriatric population suffering from cardiovascular and orthopedic diseases and supporting government norms will further support the regional progression.
Some of the notable players of the market include Hydromer, DSM Biomedical, SurModics, Biocoat, AST Products, Applied Materials, Inc. (Picosun), and Specialty Coatings System.